Novonix appoints Mike O'Kronley to its board of directors

Novonix Limited has reported a change in its board of directors.

Accepted by SEC EDGAR 12/15/2025 - 06:00 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Novonix Limited has reported a change in its board of directors. The company submitted a report to U.S. regulators highlighting an attached announcement from the Australian Securities Exchange.

The exhibit notes the appointment of Mike O'Kronley to the Board of Directors, dated December 15, 2025. This update formally records the new board role for investors who follow Novonix through U.S. markets.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Novonix (NVX) disclose in this December 2025 report?

Novonix discloses an attached announcement from the ASX documenting the appointment of Mike O'Kronley to its Board of Directors, dated December 15, 2025.

Who is being appointed to the Novonix (NVX) Board of Directors?

The report shows that Mike O'Kronley is being appointed to the Novonix Limited Board of Directors, as described in the attached ASX announcement.

What is Exhibit 99.1 in the Novonix (NVX) December 2025 report?

Exhibit 99.1 is an ASX Announcement titled "Appointment of Mike O'Kronley to the Board of Directors", dated December 15, 2025.

Does this Novonix (NVX) report include financial results or earnings data?

No financial or earnings data are presented in this report; it primarily highlights the board appointment of Mike O'Kronley via the attached ASX announcement.

Who signed the Novonix (NVX) December 15, 2025 report?

The report is signed on behalf of Novonix Limited by Robert Long, Chief Financial Officer, dated December 15, 2025.

Why is the Novonix (NVX) board appointment routed through a U.S. report?

As a foreign private issuer, Novonix Limited uses this report to share its ASX board appointment announcement with investors who follow the company through U.S. regulatory channels.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of December, 2025

001-41208

(Commission File Number)

NOVONIX LIMITED

(Translation of registrant’s name into English)

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXHIBIT INDEX

Exhibit No.		Description
Exhibit 99.1		ASX Announcement (Appointment of Mike O'Kronley to the Board of Directors) dated December 15, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NOVONIX LIMITED
By:		/s/ Robert Long
		Robert Long
		Chief Financial Officer

Date: December 15, 2025